Chemoinformaics analysis of 1,6-Octadiene, 3-ethoxy-3,7-dimethyl-
| Molecular Weight | 182.307 | nRot | 6 |
| Heavy Atom Molecular Weight | 160.131 | nRig | 2 |
| Exact Molecular Weight | 182.167 | nRing | 0 |
| Solubility: LogS | -4.129 | nHRing | 0 |
| Solubility: LogP | 4.205 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 35.5114 |
| nHD | 0 | BPOL | 23.8066 |
| QED | 0.569 |
| Synth | 3.615 |
| Natural Product Likeliness | 2.105 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.608 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.377 |
| MDCK | 0.0000224 |
| BBB | 0.098 |
| PPB | 0.907103 |
| VDSS | 1.447 |
| FU | 0.103783 |
| CYP1A2-inh | 0.351 |
| CYP1A2-sub | 0.601 |
| CYP2c19-inh | 0.393 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.081 |
| CYP2c9-sub | 0.339 |
| CYP2d6-inh | 0.048 |
| CYP2d6-sub | 0.192 |
| CYP3a4-inh | 0.41 |
| CYP3a4-sub | 0.36 |
| CL | 9.278 |
| T12 | 0.294 |
| hERG | 0.018 |
| Ames | 0.009 |
| ROA | 0.013 |
| SkinSen | 0.358 |
| Carcinogencity | 0.172 |
| EI | 0.966 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.627912 |